These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26889247)

  • 21. A phase II study of carboplatin, pemetrexed, and bevacizumab followed by erlotinib and bevacizumab maintenance for non-squamous non-small cell lung cancer with wild-type EGFR (HOT1101).
    Takashina T; Asahina H; Oizumi S; Yamada N; Harada M; Takamura K; Yokouchi H; Harada T; Honjo O; Ogi T; Morikawa N; Kinoshita I; Honda R; Nakano K; Kanazawa K; Amano T; Dosaka-Akita H; Isobe H; Nishimura M;
    Int J Clin Oncol; 2018 Dec; 23(6):1060-1069. PubMed ID: 30027464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I Study Evaluating the Combination of Afatinib with Carboplatin and Pemetrexed After First-line EGFR-TKIs.
    Watanabe S; Yamaguchi OU; Masumoto AI; Maeno Y; Kawashima Y; Ishimoto O; Sugawara S; Yoshizawa H; Kikuchi T; Nukiwa T; Kobayashi K
    Anticancer Res; 2018 Aug; 38(8):4699-4704. PubMed ID: 30061238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metachronous rectal metastasis from pulmonary adenocarcinoma after 11 years of chemo-, immuno-, and radiotherapy for recurrent lesions: a case report.
    Suzuki Y; Imasato M; Nakahara Y; Naito A; Mikamori M; Ohtsuka M; Furukawa K; Moon JH; Asaoka T; Kishi K; Yasuoka H; Komuta K; Akamatsu H
    Surg Case Rep; 2019 Oct; 5(1):151. PubMed ID: 31650415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II Trial of Carboplatin and Pemetrexed Plus Bevacizumab with Maintenance Bevacizumab as a First-line Treatment for Advanced Non-squamous Non-small Cell Lung Cancer in Elderly Patients.
    Takeoka H; Yamada K; Naito Y; Matsuo N; Ishii H; Tokito T; Azuma K; Ichiki M; Hoshino T
    Anticancer Res; 2018 Jun; 38(6):3779-3784. PubMed ID: 29848743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Choroidal metastasis with adenocarcinoma of the lung treated with gefitinib.
    Inoue M; Watanabe Y; Yamane S; Kobayashi S; Arakawa A; Tsukahara T; Kaneko T; Kadonosono K
    Eur J Ophthalmol; 2010; 20(5):963-5. PubMed ID: 20383850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase II study of bevacizumab with carboplatin-pemetrexed in non-squamous non-small cell lung carcinoma patients with malignant pleural effusions: North East Japan Study Group Trial NEJ013A.
    Usui K; Sugawara S; Nishitsuji M; Fujita Y; Inoue A; Mouri A; Watanabe H; Sakai H; Kinoshita I; Ohhara Y; Maemondo M; Kagamu H; Hagiwara K; Kobayashi K;
    Lung Cancer; 2016 Sep; 99():131-6. PubMed ID: 27565928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platinum-Vinorelbine Induction Chemotherapy plus Bevacizumab With and Without Pemetrexed Switch Maintenance in Advanced NSCLC.
    Michelsen L; Sørensen JB
    Anticancer Res; 2015 Nov; 35(11):6255-9. PubMed ID: 26504059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pemetrexed Continuation Maintenance versus Conventional Platinum-Based Doublet Chemotherapy in EGFR-Negative Lung Adenocarcinoma: Retrospective Analysis.
    Paik SS; Hwang IK; Park MJ; Lee SH
    Tuberc Respir Dis (Seoul); 2018 Apr; 81(2):148-155. PubMed ID: 29527843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pemetrexed Singlet Versus Nonpemetrexed-Based Platinum Doublet as Second-Line Chemotherapy after First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Failure in Non-small Cell Lung Cancer Patients with EGFR Mutations.
    Park S; Keam B; Kim SH; Kim KH; Kim YJ; Kim JS; Kim TM; Lee SH; Kim DW; Lee JS; Heo DS
    Cancer Res Treat; 2015 Oct; 47(4):630-7. PubMed ID: 25687850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lung cancer and intraocular metastasis in gestation: Clinical experiences of a rare case.
    Lin L; Sun J; Wang J
    Thorac Cancer; 2020 Sep; 11(9):2723-2726. PubMed ID: 32691515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of chemotherapy after first-line gefitinib therapy in EGFR mutation-positive advanced non-small cell lung cancer-data from a randomized Phase III study comparing gefitinib with carboplatin plus paclitaxel (NEJ002).
    Miyauchi E; Inoue A; Kobayashi K; Maemondo M; Sugawara S; Oizumi S; Isobe H; Gemma A; Saijo Y; Yoshizawa H; Hagiwara K; Nukiwa T;
    Jpn J Clin Oncol; 2015 Jul; 45(7):670-6. PubMed ID: 25877748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Choroidal metastases as the sole initial presentation of metastatic lung cancer: case report and review of literature.
    Salah S; Khader J; Yousef Y; Salem A; Al-Hussaini M; Al-Asady R
    Nepal J Ophthalmol; 2012; 4(2):339-42. PubMed ID: 22864048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Male Breast Carcinoma Metastatic to the Choroid: A Case Report and Opinions of Management.
    Fu W; Zheng S; Zhou J; Lu K; Lu Y; Guo G
    Cancer Manag Res; 2022; 14():525-534. PubMed ID: 35173486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unusual Case of Papillary Thyroid Carcinoma with Choroidal Metastasis.
    Makhija C; Su YB; Goldner W
    Thyroid; 2015 Jul; 25(7):860-4. PubMed ID: 25872533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complete Disappearance of Choroidal Metastasis from Lung Adenocarcinoma Treated with Bevacizumab and Chemotherapy.
    Kourie HR; Antoun J; Schakal A; Nasr E; Sahyoun M; Kattan J
    Case Rep Ophthalmol Med; 2015; 2015():142408. PubMed ID: 26064733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An indirect comparison of the efficacy of bevacizumab plus carboplatin and paclitaxel versus pemetrexed with cisplatin in patients with advanced or recurrent non-squamous adenocarcinoma non-small cell lung cancer.
    Nuijten MJ; Aultman R; Carpeño Jde C; Vergnenègre A; Chouaid C; Walzer S; Siebert U
    Curr Med Res Opin; 2011 Nov; 27(11):2193-201. PubMed ID: 21970659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of third-line pemetrexed monotherapy versus pemetrexed combination with bevacizumab in patients with advanced EGFR mutation-positive lung adenocarcinoma.
    Zhou CZ; Qin YY; Xie ZH; Zhang JX; Ou-Yang M; Li SY; Chen RC
    Chin J Cancer Res; 2014 Dec; 26(6):705-10. PubMed ID: 25561769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pembrolizumab plus chemotherapy for first-line treatment of metastatic nonsquamous non-small-cell lung cancer: a network meta-analysis.
    Frederickson AM; Arndorfer S; Zhang I; Lorenzi M; Insinga R; Arunachalam A; Burke TA; Simon GR
    Immunotherapy; 2019 Apr; 11(5):407-428. PubMed ID: 30712477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment with pemetrexed, Carboplatin, and bevacizumab for platinum-resistant adenocarcinoma of the lung.
    Wada S; Fujimoto N; Gemba K; Asano M; Fuchimoto Y; Ono K; Ozaki S; Kishimoto T
    Case Rep Oncol Med; 2012; 2012():821280. PubMed ID: 22779020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II trial of carboplatin, S-1, and gefitinib as first-line triplet chemotherapy for advanced non-small cell lung cancer patients with activating epidermal growth factor receptor mutations.
    Tamiya A; Tamiya M; Shiroyama T; Saijo N; Nakatani T; Minomo S; Tsuji T; Takeuchi N; Omachi N; Kurata K; Suzuki H; Okamoto N; Okishio K; Hirashima T; Atagi S
    Med Oncol; 2015 Mar; 32(3):40. PubMed ID: 25616723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.